Showing results (1611-1620 of 1,670) with videos related to

Sort By:
Pageof 167
Journal of Immunotherapy and Precision Oncology|August 29, 2022
Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University ExperienceDylan J Martini, T Anders Olsen, Subir Goyal, et al.
Leukemia|August 17, 2011
KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinibD Marin, I H Gabriel, S Ahmad, et al.
Msystems|November 9, 2016
ASM Journals Eliminate Impact Factor Information from Journal WebsitesArturo Casadevall, Stefano Bertuzzi, Michael J Buchmeier, et al.
Leukemia|November 20, 2009
Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA allelesB E Shaw, N P Mayor, N H Russell, et al.
Frontiers in Oncology|July 5, 2021
Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint BlockadeT Anders Olsen, Dylan J Martini, Subir Goyal, et al.
Scientific Reports|December 1, 2023
Exploring relationships among multi-disciplinary assessments for knee joint health in service members with traumatic unilateral lower limb loss: a two-year longitudinal investigationJoseph G Wasser, Brad D Hendershot, Julian C Acasio, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 22, 2003
Clinical characteristics of 13 solid organ transplant recipients with ganciclovir-resistant cytomegalovirus infectionC M Isada, B Yen-Lieberman, N S Lurain, et al.
Frontiers in Oncology|July 26, 2021
Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint InhibitorsDylan J Martini, T Anders Olsen, Subir Goyal, et al.
Clinical Genitourinary Cancer|December 19, 2021
Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma PatientsDylan J Martini, Sean T Evans, Yuan Liu, et al.
Parkinsonism & Related Disorders|October 15, 2013
Dietary fat intake, pesticide use, and Parkinson's diseaseFreya Kamel, Samuel M Goldman, David M Umbach, et al.
Pageof 167